🇺🇸 FDA
Patent

US 9650648

Methods and compositions for treatment of a genetic condition

granted A61PA61P43/00A61P7/00

Quick answer

US patent 9650648 (Methods and compositions for treatment of a genetic condition) held by Sangamo Biosciences, Inc. expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P43/00, A61P7/00, A61P7/06